TD Cowen analyst Gary Taylor lowered the firm’s price target on HCA Healthcare to $360 from $371 and keeps a Buy rating on the shares. The firm updated its model following its solid Q1 results which nevertheless missed Cowen’s EBITDA estimate.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $367 from $356 at Barclays
- HCA Healthcare Announces Q1 Results and Shareholder Dividend
- HCA Healthcare backs FY24 EPS view $19.70-$21.20, consensus $20.64
- HCA Healthcare reports Q1 adjusted EPS $5.36, consensus $5.01
- Options Volatility and Implied Earnings Moves Today, April 26, 2024